April9 update reported they implemented yield and purity enhancements in the manufacturing of Brilacidin for the bulk production and other efforts associated with the chemical processes aiming to achieve drug supply optimization for commercial use. I believe we could get another update regarding B being optimized and ready to go. I agree we are very close to deal time.

“Making these enhancements to Brilacidin is a crucial development step to ensure consistent, high-quality drug substance,” commented Arthur P. Bertolino, MD, PhD, MBA, President and Chief Medical Officer at Innovation Pharmaceuticals. “The Company believes that its Brilacidin franchise will one day provide patients and providers with multiple, much-needed novel and effective medicines.”